Skip to content
★ Sign in to follow
BM

Barry Mills

Lexicon Pharmaceuticals, Inc.
Total declarations
12
Company
1
▲ Purchases (12 ops.)
€77k
▼ Sales (0 ops.)
—

Latest filing published 31 Aug 2006 for Lexicon Pharmaceuticals, INC., €804.

Insider track record

Disclosed buys
12
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
12
Positive at T+90
0%
Median T+90
-19.6%

Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Barry Mills: trading record in brief

Barry Mills is a declared insider of Lexicon Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 12 filings, every one of them for a trade on 18 August 2006.

The open-market record is one-sided, with 12 purchases worth €77k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €2,904 and half below. For 12 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -19.6%. These figures describe past trades and do not predict future prices.

The latest filing, published on 31 August 2006, reports an open-market purchase of €804 in Lexicon Pharmaceuticals, Inc. Typically, a trade is published a median of 13 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Barry Mills

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations